- Home
- Services
- usa california
- successful clinical
Refine by
Successful Clinical Services In Usa California
6 services found
Manufactured by:AnaBios Corporation based inSan Diego, CALIFORNIA (USA)
Broadly defined, cardiovascular disease is the leading cause of death for men and women across most racial and ethnic groups in the United States with one person dying approximately every 34 seconds1. To drive successful clinical translation of new cardiovascular medicine, AnaBios develops relevant human ex vivo platforms for many cardiovascular diseases, ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Why partner with Signatera for your clinical trial? Clinically validated across multiple solid tumors, Signatera has shown to predict relapse in >98% of patients without further treatment. Experienced team with Global reach: CE Mark, three FDA Breakthrough Device Designations, 8 Non-Significant Risk (NSR) determinations. >60 Natera IP assets covering ctDNA MRD and ...
Manufactured by:Advanced Cell Diagnostics, Inc. based inNewark, CALIFORNIA (USA)
There is growing interest in RNA-based biomarkers and measuring RNA expression holds great promise for stratifying patients based on drug response, drug efficacy and risk of side effects. RNAscope in situ hybridization enables molecular detection in a morphological context. It provides the cellular resolution required to evaluate tissue heterogeneity and to potentially better screen and select ...
Manufactured by:XILIS, Inc. based inDurham, NORTH CAROLINA (USA)
Xilis’ rapid and scalable patient-derived MicroOrganoSphere (MOS) technology platform enhances precision medicine and pharmaceutical drug discovery and development. Compared to conventional patient-derived models, MOS provides faster, higher-throughput, and greater cost savings, as well as more predictive and accurate results. MOS can be used in large-scale pharmacogenomic studies that are ...
Manufactured by:Siemens Healthcare GmbH based inErlangen, GERMANY
The pivotal, multi-center PRECISE trial demonstrated the safety and feasibility of the remote-controlled CorPath 200 System for use during PCI. The study met its clinical and technical endpoints, with the operator experiencing a significant reduction in radiation exposure. There were no reports of device-related complications and an overall clinical ...
Manufactured by:Siemens Healthcare GmbH based inErlangen, GERMANY
The PRECISION Study was a multicenter, post-market registry of robotic PCI using the Corindus CorPath 200 System. The purpose of the study was to collect data on the routine patterns of use, safety and effectiveness, including the clinical and technical performance of the CorPath 200 System, in the delivery and manipulation of coronary guidewires and stent/balloon catheters during PCI ...